Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 62571-86-2 | Product Number: C1580
Captopril
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- (S)-(-)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
- (S)-(-)-1-(3-Mercapto-2-methylpropionyl)-L-proline
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
€116.00
|
3 | ≥40 |
|
| 25G |
€374.00
|
1 | 22 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | C1580 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__9H__1__5NO__3S = 217.28 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive |
| CAS RN | 62571-86-2 |
| Reaxys Registry Number | 477887 |
| PubChem Substance ID | 87566575 |
| SDBS (AIST Spectral DB) | 16831 |
| Merck Index (14) | 1774 |
| MDL Number | MFCD00168073 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity( Potassium iodate Method) | min. 98.0 % |
| Melting point | 105.0 to 110.0 °C |
| Specific rotation [a]20/D | -125 to -134 deg(C=1, EtOH) |
| Solubility in Methanol | almost transparency |
Properties (reference)
| Melting Point | 106 °C |
| Specific Rotation | -127.5° (C=1,EtOH) |
GHS
Related Laws:
| EC Number | 263-607-1 |
| RTECS# | UY0550000 |
Transport Information:
| HS Number | 2933998090 |
Application
Captopril: An Orally Active ACE Inhibitor
Captopril (SQ 14225) is an orally active angiotensin-converting enzyme inhibitor often called ACE inhibitor. Angiotensin I is converted by angiotensin-converting enzyme (ACE) to angiotensin II, a potent endogenous vasoconstrictor substance. ACE inhibitors occupy the active center of ACE so that cleavage of angiotensin I is inhibited competitively. The elevation of blood pressure is then attenuated or abolished by diminished production of angiotensin II. (The product is for research purpose only.)
References
- SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme
- Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme
- Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy
- Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica
- Captopril (a review on the history, synthesis, properties, methods of detection, and pharmacology)
- Automated determination of captopril by flow and sequential injection analysis: a review
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.